Global Information
회사소개 | 문의 | 비교리스트

세계의 수술부위 감염 관리 시장 : 성장, 동향, 예측(2019-2024년)

Surgical Site Infection Control Market - Growth, Trends, and Forecast (2019 - 2024)

리서치사 Mordor Intelligence LLP
발행일 2019년 03월 상품 코드 802343
페이지 정보 영문
가격
US $ 4,250 ₩ 5,117,000 PDF by E-mail (Single User License)
US $ 4,750 ₩ 5,719,000 PDF by E-mail (Team License: Up to 7 Users)
US $ 6,000 ₩ 7,224,000 PDF by E-mail (Site License)
US $ 7,500 ₩ 9,030,000 PDF by E-mail (Corporate License)


세계의 수술부위 감염 관리 시장 : 성장, 동향, 예측(2019-2024년) Surgical Site Infection Control Market - Growth, Trends, and Forecast (2019 - 2024)
발행일 : 2019년 03월 페이지 정보 : 영문

현재 세계의 수술부위 감염 관리(Surgical Site Infection Control) 시장은 성장 단계에 있으며, 북미 등의 선진국 및 병원 등에 의해 독점되고 있습니다. 증가하는 원내감염 및 수술 건수의 증가가 시장의 성장을 촉진하고 있습니다.

세계의 수술부위 감염 관리 시장에 대해 조사했으며, 시장 동향과 부문별 동향, 지역별 예측, 시장 참여 기업의 개요에 대해 정리하여 전해드립니다.

제1장 서론

제2장 조사 방법

제3장 개요

제4장 시장 동향

  • 시장 개요
  • 시장 성장 촉진요인
    • 원내감염의 증가
    • 병원 감염 방지와 관리에 관한 규제 가이드라인
    • 수술 건수의 증가
    • 급속한 고령화
  • 시장 성장 저해요인
    • 원내감염 방지와 관리에 대한 인식 부족
    • 외래 치료의 이용 확대
  • Porter의 산업 분석

제5장 시장 세분화

  • 제품별
    • 수동 재처리제
    • 소독제
    • 수술용 스크럽(Surgical Scrubs)
    • 헤어 클리퍼
    • 수술용 드레이프
    • 수술용 이리게이션(Surgical Irrigation)
    • 피부 처리제
    • 의료용 부직포
    • 수술용 장갑
    • 기타
  • 수술/시술별
    • 백내장 수술
    • 제왕절개
    • 치과 수복
    • 위 바이패스
    • 기타
  • 감염 종류별
    • 표면 절개 감염
    • 심부 절개 감염
    • 장기·공간 감염
  • 최종사용자별
    • 병원
    • 외래 외과 센터
  • 지역별
    • 북미
    • 유럽
    • 아시아태평양
    • 중동·아프리카
    • 남미

제6장 경쟁 환경

  • 기업 개요
    • 3M
    • Becton, Dickinson and Company
    • Belimed AG
    • bioMerieux SA
    • Getinge Group
    • Johnson & Johnson
    • Kimberly-Clark Corporation
    • Sotera Health
    • Ansell Limited
    • Steris Corporation
    • Lac-Mac Limited
    • Pacon Manufacturing Corp.
    • American Polyfilm Inc.

제7장 시장 기회와 향후 동향

KSA 19.03.18

이 페이지에 게재되어 있는 내용은 최신판과 약간 차이가 있을 수 있으므로 영문목차를 함께 참조하여 주시기 바랍니다. 기타 자세한 사항은 문의 바랍니다.

Market Overview

Currently, the global SSI control market is in the growing phase and is dominated by hospitals and developed regions, like North America. Increasing hospital-acquired infections and number of surgeries are increasingly driving the SSI control market across the world. Increased focus on preventing SSI through appropriate measures has further augmented the market in developed regions. Awareness about surgical site infections is also higher in the developed regions. This has led to higher adoption of SSI control products, thus, preventing infections among people. The increasing geriatric population has also impacted this market positively.

Scope of the Report

As per the scope of this report, surgical site infection (SSI) is an infection that occurs after surgery, in that part of the body where the surgery has been done. Surgical site infections can be superficial, deep incisional, or organ related.

Key Market Trends

Superficial Incisional SSI Segment is Expected to Exhibit Fastest Growth Rate Over the Forecast Period

Surgical site infection (SSI) represents the most common nosocomial infection and accounts for about 15% of all nosocomial infections. Surgical site infection is one of the most common complications of gastrointestinal surgery. This type of surgical procedures and wound closure methods affect the incidence of superficial incisional surgical site infection. There is an increase in the incidence of superficial incisional SSI infections, as compared to deep incisional SSI and organ or space SSIs.

North America Captured the Largest Market Share and is Expected to Retain its Dominance

North America dominated the surgical site infection control market, with the United States contributing the largest share in the regional revenue. SSIs are considered the most common (tied with pneumonia) healthcare-associated infection (HAI) among inpatients in acute care hospitals in the United States. SSIs occur in an estimated 2-5% of patients undergoing inpatient surgery. The estimated annual incidence of SSIs in the United States ranges from 160,000 to 300,000, and the estimated annual cost ranges from USD 3.5 billion to USD 10 billion. Hence, the rising need for the prevention of SSI can be attributed to the rising number of surgical procedures performed in the United States.

Competitive Landscape

3M Company, Becton, Dickinson and Company, Biomerieux SA, Getinge Grou,p and Johnson & Johnson are some of the major players in the surgical site infection control market The competitive rivalry of the market studied has intensified, owing to the constant product innovations across the world.

Reasons to Purchase this report:

  • The market estimate (ME) sheet in Excel format
  • Report customization as per the client's requirements
  • 3 months of analyst support

Table of Contents

1 INTRODUCTION

  • 1.1 Study Deliverables
  • 1.2 Study Assumptions
  • 1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Rise in Hospital Acquired Infection
    • 4.2.2 Regulatory Guidelines for Hospital Infection Prevention and Control
    • 4.2.3 Increasing Number of Surgeries
    • 4.2.4 Rapidly Growing Geriatric Population
  • 4.3 Market Restraints
    • 4.3.1 Lack of Awareness of Hospital Infection Prevention and Control
    • 4.3.2 Increased Use of Outpatient Treatment
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

  • 5.1 By Product
    • 5.1.1 Manual Reprocessors Solution
    • 5.1.2 Disinfectants
      • 5.1.2.1 Hand Disinfectants
      • 5.1.2.2 Skin Disinfectants
    • 5.1.3 Surgical Scrubs
    • 5.1.4 Hair Clippers
    • 5.1.5 Surgical Drapes
    • 5.1.6 Surgical Irrigation
    • 5.1.7 Skin Preparation Solution
    • 5.1.8 Medical Nonwovens
    • 5.1.9 Surgical Gloves
    • 5.1.10 Other Products
  • 5.2 By Surgery/Procedure
    • 5.2.1 Cataract Surgery
    • 5.2.2 Cesarean Section
    • 5.2.3 Dental Restoration
    • 5.2.4 Gastric Bypass
    • 5.2.5 Other Surgeries/Procedures
  • 5.3 By Type of Infection
    • 5.3.1 Superficial Incisional SSI
    • 5.3.2 Deep Incisional SSI
    • 5.3.3 Organ or Space SSI
  • 5.4 By End User
    • 5.4.1 Hospitals
    • 5.4.2 Ambulatory Surgical Centers
  • 5.5 Geography
    • 5.5.1 North America
      • 5.5.1.1 United States
      • 5.5.1.2 Canada
      • 5.5.1.3 Mexico
    • 5.5.2 Europe
      • 5.5.2.1 Germany
      • 5.5.2.2 United Kingdom
      • 5.5.2.3 France
      • 5.5.2.4 Italy
      • 5.5.2.5 Spain
      • 5.5.2.6 Rest of Europe
    • 5.5.3 Asia-Pacific
      • 5.5.3.1 China
      • 5.5.3.2 Japan
      • 5.5.3.3 India
      • 5.5.3.4 Australia
      • 5.5.3.5 South Korea
      • 5.5.3.6 Rest of Asia-Pacific
    • 5.5.4 Middle East & Africa
      • 5.5.4.1 GCC
      • 5.5.4.2 South Africa
      • 5.5.4.3 Rest of Middle East & Africa
    • 5.5.5 South America
      • 5.5.5.1 Brazil
      • 5.5.5.2 Argentina
      • 5.5.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 3M
    • 6.1.2 Becton, Dickinson and Company
    • 6.1.3 Belimed AG
    • 6.1.4 bioMerieux SA
    • 6.1.5 Getinge Group
    • 6.1.6 Johnson & Johnson
    • 6.1.7 Kimberly-Clark Corporation
    • 6.1.8 Sotera Health
    • 6.1.9 Ansell Limited
    • 6.1.10 Steris Corporation
    • 6.1.11 Lac-Mac Limited
    • 6.1.12 Pacon Manufacturing Corp.
    • 6.1.13 American Polyfilm Inc.

7 MARKET OPPORTUNITIES AND FUTURE TRENDS

Back to Top
전화 문의
F A Q